Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SANA · against 494 other Healthcare companies of similar size
Ranked #431 of 495 · scores higher than 13% of peers · safety percentile 15
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)45 peers with a safety percentile of 10–19, including SANA · Click a bar to see the companies
Mainly because of its beta, current ratio and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | SANA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 463 reported | 0.52× | 0.17× | 24% | 33% | |
| BetaLower is better · 472 reported | 2.13 | 0.41 | 3% | 33% | |
| Current ratioHigher is better · 489 reported | 1.38× | 2.86× | 19% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 1.1B USD | 100 | ||
| 4 | 1.0B USD | 99 | 35 | |
| 5 | 421M USD | 99 | 52 | |
| 427 | 885M USD | 15 | 33 | |
| 428 | 5.9B CNY (≈$824M) | 15 | 26 | |
| 429 | 70.2B JPY (≈$477M) | 15 | 59 | |
| 430 | 1.2B USD | 15 | 39 | |
| 431 | 730M USD | 15 | 11 | |
| 432 | 468M EUR (≈$514M) | 15 | 57 | |
| 433 | 8.9B CNY (≈$1.2B) | 15 | 42 | |
| 434 | 782M USD | 15 | 35 | |
| 435 | 1.1B CAD (≈$774M) | 14 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score